We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$701M
AUM Growth
+$66.8M
Cap. Flow
+$49.7M
Cap. Flow %
7.1%
Top 10 Hldgs %
47.13%
Holding
388
New
53
Increased
160
Reduced
59
Closed
14

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.1M
2
BDX icon
Becton Dickinson
BDX
+$3.12M
3
ORCL icon
Oracle
ORCL
+$2.96M
4
TRV icon
Travelers Companies
TRV
+$2.96M
5
ABT icon
Abbott
ABT
+$2.93M

Sector Composition

Rank Sector Weight
1 Technology 4.99%
2 Financials 4.98%
3 Healthcare 4.2%
4 Industrials 3.81%
5 Consumer Discretionary 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IUSG icon
201
iShares Core S&P US Growth ETF
IUSG
$33.9B
$183K 0.03%
3,790
GS icon
202
Goldman Sachs
GS
$303B
$181K 0.03%
816
+34
+4% +$7.55K
MNRO icon
203
Monro
MNRO
$398M
$178K 0.03%
4,255
+665
+19% +$33.1K
IUSV icon
204
iShares Core S&P US Value ETF
IUSV
$27.7B
$173K 0.02%
3,396
BIO icon
205
Bio-Rad Laboratories Class A
BIO
$9.42B
$170K 0.02%
+751
New +$164K
NVS icon
206
Novartis
NVS
$297B
$165K 0.02%
2,202
UHT
207
Universal Health Realty Income Trust
UHT
$594M
$159K 0.02%
+2,000
New +$144K
IYR icon
208
iShares US Real Estate ETF
IYR
$4.57B
$151K 0.02%
1,890
DD icon
209
DuPont de Nemours
DD
$19.2B
$151K 0.02%
943
UNP icon
210
Union Pacific
UNP
$174B
$147K 0.02%
1,348
BMY icon
211
Bristol-Myers Squibb
BMY
$132B
$142K 0.02%
2,553
-3,820
-60% -$208K
PX
212
DELISTED
Praxair Inc
PX
$135K 0.02%
1,015
AFL icon
213
Aflac
AFL
$62.6B
$131K 0.02%
+3,360
New +$126K
BP icon
214
BP
BP
$107B
$129K 0.02%
+4,207
New +$131K
KMB icon
215
Kimberly-Clark
KMB
$36.5B
$128K 0.02%
995
MMU
216
Western Asset Managed Municipals Fund
MMU
$554M
$128K 0.02%
9,300
RPM icon
217
RPM International
RPM
$15B
$128K 0.02%
2,340
ARE icon
218
Alexandria Real Estate Equities
ARE
$8.56B
$125K 0.02%
+1,038
New +$121K
AAON icon
219
Aaon
AAON
$7.77B
$121K 0.02%
+4,913
New +$119K
ESRX
220
DELISTED
Express Scripts Holding Company
ESRX
$120K 0.02%
1,877
AXP icon
221
American Express
AXP
$230B
$115K 0.02%
+1,370
New +$108K
GOOGL icon
222
Alphabet (Google) Class A
GOOGL
$4.33T
$115K 0.02%
2,480
XLNX
223
DELISTED
Xilinx Inc
XLNX
$115K 0.02%
1,785
AAL icon
224
American Airlines Group
AAL
$10.6B
$112K 0.02%
2,230
CCI icon
225
Crown Castle
CCI
$32.2B
$112K 0.02%
1,113
+53
+5% +$5.21K

Similar funds

Capital Analysts LLC's Q2 2017 Portfolio in Review

As of Q2 2017, Capital Analysts LLC held 388 positions worth $701M, up 11% from $634M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Capital Analysts LLC deployed $49.7M of net new capital in Q2 2017, opening 53 new positions and adding to 160 existing holdings. Its largest new stake was Apple: 110,832 shares worth $3.99M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, up from 3.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Boston Properties, an estimated $2.49M trimmed.

  • Capital Analysts LLC's largest Q2 2017 buy was Apple: 110,832 shares worth $3.99M.
  • Capital Analysts LLC added most to Oracle in Q2 2017, an estimated $2.96M increase.
  • Capital Analysts LLC's biggest Q2 2017 reduction was Boston Properties, cutting an estimated $2.49M.
  • Capital Analysts LLC fully exited General Mills in Q2 2017, selling an estimated $938K.
  • Capital Analysts LLC's ten largest holdings make up 47% of its $701M portfolio in Q2 2017.
  • Capital Analysts LLC opened 53 new positions and closed 14 in Q2 2017.
  • Capital Analysts LLC's portfolio value rose 11% quarter-over-quarter to $701M.

Based on Capital Analysts LLC's 13F filing for Q2 2017, filed 8 Aug 2017.